These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21865343)

  • 1. ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.
    Calpe E; Codony C; Baptista MJ; Abrisqueta P; Carpio C; Purroy N; Bosch F; Crespo M
    Blood; 2011 Oct; 118(16):4401-10. PubMed ID: 21865343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
    Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
    Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
    Redondo-Muñoz J; José Terol M; García-Marco JA; García-Pardo A
    Blood; 2008 Jan; 111(1):383-6. PubMed ID: 17890452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.
    Chen L; Huynh L; Apgar J; Tang L; Rassenti L; Weiss A; Kipps TJ
    Blood; 2008 Mar; 111(5):2685-92. PubMed ID: 18048647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia.
    Chen J; Sathiaseelan V; Reddy Chilamakuri CS; Roamio Franklin VN; Jakwerth CA; D'Santos C; Ringshausen I
    Blood Adv; 2024 Mar; 8(5):1167-1178. PubMed ID: 38113463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
    Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
    Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
    Wagner M; Oelsner M; Moore A; Götte F; Kuhn PH; Haferlach T; Fiegl M; Bogner C; Baxter EJ; Peschel C; Follows GA; Ringshausen I
    Blood; 2016 Jan; 127(4):436-48. PubMed ID: 26508782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia.
    Chen L; Apgar J; Huynh L; Dicker F; Giago-McGahan T; Rassenti L; Weiss A; Kipps TJ
    Blood; 2005 Mar; 105(5):2036-41. PubMed ID: 15514014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation.
    Calpe E; Purroy N; Carpio C; Abrisqueta P; Carabia J; Palacio C; Castellví J; Crespo M; Bosch F
    PLoS One; 2013; 8(12):e81221. PubMed ID: 24312539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
    Risnik D; Colado A; Podaza E; Almejún MB; Elías EE; Bezares RF; Fernández-Grecco H; Seija N; Oppezzo P; Borge M; Gamberale R; Giordano M
    Cancer Immunol Immunother; 2020 May; 69(5):813-824. PubMed ID: 32055920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.
    Borge M; Nannini PR; Galletti JG; Morande PE; Avalos JS; Bezares RF; Giordano M; Gamberale R
    Haematologica; 2010 May; 95(5):768-75. PubMed ID: 20145264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.
    Gobessi S; Laurenti L; Longo PG; Sica S; Leone G; Efremov DG
    Blood; 2007 Mar; 109(5):2032-9. PubMed ID: 17038529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes.
    Shannon LA; Calloway PA; Welch TP; Vines CM
    J Biol Chem; 2010 Dec; 285(50):38781-7. PubMed ID: 20889506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
    Catusse J; Leick M; Groch M; Clark DJ; Buchner MV; Zirlik K; Burger M
    Mol Cancer; 2010 Nov; 9():297. PubMed ID: 21092185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
    Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
    J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.